Latest filing published 17 Dec 2025 for Evoke Pharma Inc.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Cam L. Garner across 6 companies, led by Zogenix, Inc., Cadence Pharmaceuticals Inc and Somaxon Pharmaceuticals, Inc. The record holds 37 filings, for trades running from 30 October 2006 to 16 December 2025.
On the open market, the record shows 8 purchases worth €912k and 8 sales worth €2.3M. Taken together, the sales exceed the purchases by €1.3M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant and 9 option exercises.
In size, the median ticket on the buying side is €109k. None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The latest filing, published on 17 December 2025, reports a transaction in Evoke Pharma Inc. The last purchase on record was published on 12 August 2021, which is 1,899 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations